Jasmine Chebli, PhD

Division coordinator / Innovative projects, gene therapy and genome editing
ECOGENE-21, Canada

Poster(s):

• P320 - LONG-TERM (>15 YEARS) MONITORING OF PATIENTS WITH PERSISTENT CHYLOMICRONEMIA TREATED WITH ALIPOGENE TIPARVOVEC LPL GENE-REPLACEMENT THERAPY WHO SUBSEQUENTLY RECEIVED PRECISION TG-LOWERING THERAPEUTICS
  Saturday, October 25, 2025

  12:30pm - 1:30pm ET